N. Kayacik Et Al. , "Picropodophyllin, an IGF‑1 receptor inhibitor, enhances oxaliplatin efficacy in chemoresistant colorectal cancer HCT116 cells by reducing metastatic potential," Oncology Letters , vol.29, no.5, 2025
Kayacik, N. Et Al. 2025. Picropodophyllin, an IGF‑1 receptor inhibitor, enhances oxaliplatin efficacy in chemoresistant colorectal cancer HCT116 cells by reducing metastatic potential. Oncology Letters , vol.29, no.5 .
Kayacik, N., Kurter, H., Sever, T., BAŞBINAR, Y., & ÇALIBAŞI KOÇAL, G., (2025). Picropodophyllin, an IGF‑1 receptor inhibitor, enhances oxaliplatin efficacy in chemoresistant colorectal cancer HCT116 cells by reducing metastatic potential. Oncology Letters , vol.29, no.5.
Kayacik, Nurcin Et Al. "Picropodophyllin, an IGF‑1 receptor inhibitor, enhances oxaliplatin efficacy in chemoresistant colorectal cancer HCT116 cells by reducing metastatic potential," Oncology Letters , vol.29, no.5, 2025
Kayacik, Nurcin Et Al. "Picropodophyllin, an IGF‑1 receptor inhibitor, enhances oxaliplatin efficacy in chemoresistant colorectal cancer HCT116 cells by reducing metastatic potential." Oncology Letters , vol.29, no.5, 2025
Kayacik, N. Et Al. (2025) . "Picropodophyllin, an IGF‑1 receptor inhibitor, enhances oxaliplatin efficacy in chemoresistant colorectal cancer HCT116 cells by reducing metastatic potential." Oncology Letters , vol.29, no.5.
@article{article, author={Nurcin Kayacik Et Al. }, title={Picropodophyllin, an IGF‑1 receptor inhibitor, enhances oxaliplatin efficacy in chemoresistant colorectal cancer HCT116 cells by reducing metastatic potential}, journal={Oncology Letters}, year=2025}